RenovoRx, Inc. (RNXT) stock
RNXTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$1.04+0.09 (+8.91%)
Close on Nov 17, 2026Market cap $46.93MP/E –Yield –
RenovoRx total assets
Total assets on the balance sheet at the end of each period.
RenovoRx's total assets was $11.47M at Jun 30, 2026. For fiscal 2025 it was $8.10M, down 0.3% from the year before. The highest annual figure on record is $16.29M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.10M | -0.3% |
| FY2024 | Dec 31, 2024 | $8.12M | +453.8% |
| FY2023 | Dec 31, 2023 | $1.47M | -79.8% |
| FY2022 | Dec 31, 2022 | $7.27M | -55.4% |
| FY2021 | Dec 31, 2021 | $16.29M | +750.9% |
| FY2020 | Dec 31, 2020 | $1.91M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $11.47M | -15.9% |
| Q1 FY2026 | Mar 31, 2026 | $13.96M | -12.8% |
| Q4 FY2025 | Dec 31, 2025 | $8.10M | -0.3% |
| Q3 FY2025 | Sep 30, 2025 | $11.21M | +11.7% |
| Q2 FY2025 | Jun 30, 2025 | $13.64M | +13.7% |
| Q1 FY2025 | Mar 31, 2025 | $16.01M | +234.5% |
| Q4 FY2024 | Dec 31, 2024 | $8.12M | +453.8% |
| Q3 FY2024 | Sep 30, 2024 | $10.03M | +185.1% |
| Q2 FY2024 | Jun 30, 2024 | $12.00M | +90.1% |
| Q1 FY2024 | Mar 31, 2024 | $4.79M | +5.0% |
| Q4 FY2023 | Dec 31, 2023 | $1.47M | -79.8% |
| Q3 FY2023 | Sep 30, 2023 | $3.52M | -62.0% |
| Q2 FY2023 | Jun 30, 2023 | $6.31M | -43.8% |
| Q1 FY2023 | Mar 31, 2023 | $4.56M | -67.3% |
| Q4 FY2022 | Dec 31, 2022 | $7.27M | -55.4% |
| Q3 FY2022 | Sep 30, 2022 | $9.25M | -49.1% |
| Q2 FY2022 | Jun 30, 2022 | $11.24M | +487.4% |
| Q1 FY2022 | Mar 31, 2022 | $13.95M | – |
| Q4 FY2021 | Dec 31, 2021 | $16.29M | – |
| Q3 FY2021 | Sep 30, 2021 | $18.18M | – |
| Q4 FY2020 | Dec 31, 2020 | $1.91M | – |
See a number that looks wrong?